ANGELIKA AGUDELO: Open Payments
NPI 1265057798 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,864 in 42 payments from 19 companies in 2025. Trend: 2023 $1,372 · 2024 $1,140 · 2025 $1,864
Food & beverage: $1,543Travel & lodging: $235Education: $85
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 6 | $421 |
| Janssen Biotech, Inc. | 8 | $409 |
| Ferring Pharmaceuticals Inc. | 4 | $178 |
| Astellas Pharma US Inc | 1 | $140 |
| Olympus America Inc. | 1 | $124 |
| Sumitomo Pharma America, Inc. | 5 | $117 |
| AngioDynamics, Inc. | 1 | $103 |
| Verity Pharmaceuticals Inc. | 3 | $94 |
| Dendreon Pharmaceuticals LLC | 2 | $67 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $45 |
Products named: Axonics, ERLEADA, ADSTILADRIN, Xtandi, RYBREVANT, iTIND System, GEMTESA, NANOKNIFE.
Industry payments across FL — which companies pay providers there.
